结合瘤免疫治疗的表观遗传调节剂:目前的状况和前景
Huan Zhang1, Yutong Pang1, Ling Yi2
1Department of Gastroenterology, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, 101149, China.
表观遗传调节剂可以通过调节瘤微环境和免疫反应来增强癌症免疫疗法. 这篇评论探讨了像DNA甲基转移酶抑制剂这样的表观遗传药物,以提高免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 免疫检查点抑制剂疗法在固体瘤中表现有前途,但面临着有限的疗效和毒性等挑战.
- 癌症表观遗传学通过重编程瘤细胞表型提供了治疗途径.
- 表观遗传调节对瘤发育至关重要,并影响瘤免疫微环境.
研究的目的:
- 审查表观遗传调节剂在增强癌症免疫治疗中的作用.
- 讨论特定的表观遗传抑制剂及其对免疫检查点的影响.
- 探索将表观遗传学与免疫治疗结合在一起的潜力和挑战.
主要方法:
- 审查最近的研究,将表观遗传因素与免疫检查点治疗相关联.
- 专注于DNA甲基转移酶抑制剂,胰岛素脱乙酶抑制剂,EZH2抑制剂和LSD1抑制剂.
- 分析这些表观遗传修饰如何影响瘤免疫微环境和免疫治疗反应.
主要成果:
- 表观遗传调节器可以调节瘤的免疫微环境,以提高免疫治疗的敏感性.
- 特定的表观遗传抑制剂与转录抑制有关,改变免疫检查点基因表达.
- 将表观遗传疗法与免疫疗法结合起来,有可能克服耐药性并减少细胞毒性.
结论:
- 表观遗传重编程对提高癌症免疫治疗疗效具有显著的前景.
- 将表观遗传调节剂与免疫检查点抑制剂相结合,提供了一种新的治疗策略.
- 需要进一步的临床研究来应对挑战并优化组合疗法.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
相关概念视频
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
